AstraZeneca Pharma India Limited (BOM:506820)
India flag India · Delayed Price · Currency is INR
6,970.75
-135.50 (-1.91%)
At close: Aug 31, 2026

AstraZeneca Pharma India Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-4,4775,3615,0565,0034,484
Cash & Short-Term Investments
4,4774,4775,3615,0565,0034,484
Cash Growth
-16.49%-16.49%6.05%1.04%11.58%27.27%
Accounts Receivable
-2,1371,8491,5311,075858.9
Other Receivables
-78.9143.6160.4105.1121.8
Receivables
-2,2161,9951,6931,181981.6
Inventory
-10,2735,4852,2791,9021,402
Prepaid Expenses
-112142.1109.6117.7108.2
Other Current Assets
-321.1439.6190150.480.5
Total Current Assets
-17,39913,4249,3278,3557,057
Property, Plant & Equipment
-1,175635.8648.4701.9766.9
Other Intangible Assets
--6.621.1--
Long-Term Deferred Tax Assets
-378415.6212.5206.7163
Other Long-Term Assets
-939698.6568.5576.6574.9
Total Assets
-19,89115,18110,7809,8498,566

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-7,8274,5631,9652,2791,904
Accrued Expenses
-607.5602.7767.2852.3785.3
Current Portion of Leases
-139.162.818.135.236.1
Current Income Taxes Payable
-54.1106.466.624.249.4
Current Unearned Revenue
-617.2722.4490.5398306.9
Other Current Liabilities
-573.2972.7263.7250.8244.4
Total Current Liabilities
-9,8187,0303,5713,8393,327
Long-Term Leases
-967.5294.527.836.950.2
Pension & Post-Retirement Benefits
-148.453.744.46948.2
Other Long-Term Liabilities
-229.199.517.716.626.8
Total Liabilities
-11,1637,4783,6613,9623,452

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-5050505050
Retained Earnings
-7,8896,8596,3135,0884,321
Comprehensive Income & Other
-788.6795756.4749.2743
Shareholders' Equity
8,7288,7287,7047,1195,8875,114
Total Liabilities & Equity
-19,89115,18110,7809,8498,566

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
1,1071,107357.345.972.186.3
Net Cash (Debt)
3,3713,3715,0045,0104,9314,398
Net Cash Growth
-32.64%-32.64%-0.11%1.59%12.13%29.27%
Net Cash Per Share
134.82134.82200.16200.39197.25175.92
Filing Date Shares Outstanding
252525252525
Total Common Shares Outstanding
252525252525
Working Capital
-7,5816,3945,7564,5153,730
Book Value Per Share
349.12349.12308.14284.77235.48204.56
Tangible Book Value
8,7288,7287,6977,0985,8875,114
Tangible Book Value Per Share
349.12349.12307.88283.92235.48204.56
Land
-0.34.94.94.94.9
Buildings
-12427427421.3415.2
Machinery
-402.31,1551,2081,1541,082
Construction In Progress
---2.713.322